|
We asked 40 pharma leaders, how optimistic are you about revenue growth in 2013?
| Very optimistic |
25% |
Somewhat optimistic |
33% |
| Not optimistic at all |
42% |
 |
|
|
|
|
|
|
|
3 April, 2013
|
| In this Issue |
So, Do You Have a Social Media Policy Yet?
You don’t? Oh, you do, you just didn’t tell your staff? Peter Houston takes a cross-industry look at the recent ‘development’ of social media guidelines and finds that for all pharma’s faltering progress in this area, things aren’t much different in other sectors ...Read more |
Read the Latest Pharm Exec Global Digest
In this month’s issue: The Keys to Success in Personalized Medicine; Seeing through EU Pricing Transparency; Global Patent Management Made Easy; Multichannel Pharma Marketing; Harnessing Positive Content for Reputation Management ... Read more |
Healthcare Systems in Europe "Failing Patients"
Any complacency that the world of healthcare might be feeling about advances in the ability to treat patients suffered a head-on assault at a conference in Dublin, Ireland, when one highly articulate cancer patient took the European healthcare to task ... Read more
|
NICE Responsible for Value-Based Pricing in UK
While the number of patent filings at the European Patent Office (EPO) in 2012 increased by 5.2% over 2011, pharmaceutical-based patents remained flat, and biotechnology patents dropped slightly, writes Rita Peters ... Read more
|
|
|
|
